Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Goal neglect and working memory capacity in 4- to 6-year-old children.

Marcovitch S, Boseovski JJ, Knapp RJ, Kane MJ.

Child Dev. 2010 Nov-Dec;81(6):1687-95. doi: 10.1111/j.1467-8624.2010.01503.x.

PMID:
21077857
2.

Symptomatic relief of botulinum neurotoxin/a intoxication with aminopyridines: a new twist on an old molecule.

Mayorov AV, Willis B, Di Mola A, Adler D, Borgia J, Jackson O, Wang J, Luo Y, Tang L, Knapp RJ, Natarajan C, Goodnough MC, Zilberberg N, Simpson LL, Janda KD.

ACS Chem Biol. 2010 Dec 17;5(12):1183-91. doi: 10.1021/cb1002366. Epub 2010 Oct 22.

3.

Use it or lose it: examining preschoolers' difficulty in maintaining and executing a goal.

Marcovitch S, Boseovski JJ, Knapp RJ.

Dev Sci. 2007 Sep;10(5):559-64.

PMID:
17683342
4.

The effect of commonly used vehicles on canine hematology and clinical chemistry values.

Ruble GR, Giardino OZ, Fossceco SL, Cosmatos D, Knapp RJ, Barlow NJ.

J Am Assoc Lab Anim Sci. 2006 Jan;45(1):25-9.

PMID:
16539331
5.

Dominant-submissive behavior as models of mania and depression.

Malatynska E, Knapp RJ.

Neurosci Biobehav Rev. 2005;29(4-5):715-37. Review.

PMID:
15876455
6.

Antidepressant activity of memory-enhancing drugs in the reduction of submissive behavior model.

Knapp RJ, Goldenberg R, Shuck C, Cecil A, Watkins J, Miller C, Crites G, Malatynska E.

Eur J Pharmacol. 2002 Apr 5;440(1):27-35.

PMID:
11959085
7.

Reduction of submissive behavior in rats: a test for antidepressant drug activity.

Malatynska E, Goldenberg R, Shuck L, Haque A, Zamecki P, Crites G, Schindler N, Knapp RJ.

Pharmacology. 2002 Jan;64(1):8-17.

PMID:
11731717
8.

Mutation W284L of the human delta opioid receptor reveals agonist specific receptor conformations for G protein activation.

Hosohata Y, Varga EV, Stropova D, Li X, Knapp RJ, Hruby VJ, Rice KC, Nagase H, Roeske WR, Yamamura HI.

Life Sci. 2001 Apr 6;68(19-20):2233-42.

PMID:
11358332
9.

Structural correlates for down-regulation of m1 and m2 muscarinic receptor subtypes.

Malatynska E, Waite S, Wei HB, Knapp RJ, Yamamura HI, Roeske WR.

Brain Res Bull. 1998 Oct;47(3):285-90.

PMID:
9865862
10.

[125I-Tyr1]biphalin binding to opioid receptors of rat brain and NG108-15 cell membranes.

Slaninova J, Appleyard SM, Misicka A, Lipkowski AW, Knapp RJ, Weber SJ, Davis TP, Yamamura HI, Hruby VJ.

Life Sci. 1998;62(14):PL199-204.

PMID:
9570343
11.

Relative efficacies of delta-opioid receptor agonists at the cloned human delta-opioid receptor.

Quock RM, Hosohata Y, Knapp RJ, Burkey TH, Hosohata K, Zhang X, Rice KC, Nagase H, Hruby VJ, Porreca F, Roeske WR, Yamamura HI.

Eur J Pharmacol. 1997 May 12;326(1):101-4.

PMID:
9178661
12.

The third extracellular loop of the human delta-opioid receptor determines the selectivity of delta-opioid agonists.

Varga EV, Li X, Stropova D, Zalewska T, Landsman RS, Knapp RJ, Malatynska E, Kawai K, Mizusura A, Nagase H, Calderon SN, Rice K, Hruby VJ, Roeske WR, Yamamura HI.

Mol Pharmacol. 1996 Dec;50(6):1619-24. Erratum in: Mol Pharmacol 1997 Aug;52(2):335.

PMID:
8967985
13.

Anatomy of the eustachian tube as demonstrated by endoluminal ultrasonography.

Helweg G, Frauscher F, Sprinzl GM, Gotwald T, Völklein C, Knapp RJ, Sögner PF, Maurer H, Frede TE, zur Nedden D.

J Ultrasound Med. 1996 Oct;15(10):673-8.

PMID:
8887238
14.

Human delta opioid receptor: functional studies on stably transfected Chinese hamster ovary cells after acute and chronic treatment with the selective nonpeptidic agonist SNC-80.

Malatynska E, Wang Y, Knapp RJ, Waite S, Calderon S, Rice K, Hruby VJ, Yamamura HI, Roeske WR.

J Pharmacol Exp Ther. 1996 Sep;278(3):1083-9.

PMID:
8819489
15.

A One-Bead One-Peptide Combinatorial Library Method for B-Cell Epitope Mapping

Lam KS, Lake D, Salmon SE, Smith J, Chen ML, Wade S, Abdul-Latif F, Knapp RJ, Leblova Z, Ferguson RD, Krchnak V V, Sepetov NF, Lebl M.

Methods. 1996 Jun;9(3):482-93.

PMID:
8812704
16.

Structure-activity relationships for SNC80 and related compounds at cloned human delta and mu opioid receptors.

Knapp RJ, Santoro G, De Leon IA, Lee KB, Edsall SA, Waite S, Malatynska E, Varga E, Calderon SN, Rice KC, Rothman RB, Porreca F, Roeske WR, Yamamura HI.

J Pharmacol Exp Ther. 1996 Jun;277(3):1284-91.

PMID:
8667189
17.

delta-Opioid receptor: the third extracellular loop determines naltrindole selectivity.

Li X, Varga EV, Stropova D, Zalewska T, Malatynska E, Knapp RJ, Roeske WR, Yamamura HI.

Eur J Pharmacol. 1996 Apr 4;300(1-2):R1-2.

PMID:
8741185
18.

Antisense oligodeoxynucleotide treatment to the brain cannabinoid receptor inhibits antinociception.

Edsall SA, Knapp RJ, Vanderah TW, Roeske WR, Consroe P, Yamamura HI.

Neuroreport. 1996 Jan 31;7(2):593-6.

PMID:
8730837
19.

Properties of TAN-67, a nonpeptidic delta-opioid receptor agonist, at cloned human delta- and mu-opioid receptors.

Knapp RJ, Landsman R, Waite S, Malatynska E, Varga E, Haq W, Hruby VJ, Roeske WR, Nagase H, Yamamura HI.

Eur J Pharmacol. 1995 Oct 15;291(2):129-34.

PMID:
8566162
20.

The role of the Val353 residue in antagonist binding to rat CCK-B receptors.

Malatynska E, Knapp RJ, Stropova D, Varga E, Yamamura HI.

Neuroreport. 1995 Jun 19;6(9):1325-9.

PMID:
7669996
21.

Molecular biology and pharmacology of cloned opioid receptors.

Knapp RJ, Malatynska E, Collins N, Fang L, Wang JY, Hruby VJ, Roeske WR, Yamamura HI.

FASEB J. 1995 Apr;9(7):516-25. Review.

PMID:
7737460
22.

Human delta opioid receptor: a stable cell line for functional studies of opioids.

Malatynska E, Wang Y, Knapp RJ, Santoro G, Li X, Waite S, Roeske WR, Yamamura HI.

Neuroreport. 1995 Mar 7;6(4):613-6.

PMID:
7605911
23.

[125I]SNF 8702: a selective radioligand for CCKB receptors.

Slaninova J, Knapp RJ, Weber SJ, Davis TP, Fang SN, Hruby VJ, Yamamura HI.

Peptides. 1995;16(2):221-4.

PMID:
7784252
24.

Efficacy of peptide and nonpeptidic agonists at the cloned human delta opioid receptor.

Knapp RJ, Waite S, Landsman R, Santoro G, De Leon IA, Malatynska E, Varga E, Nagase H, Calderon SN, Rice K, et al.

Proc West Pharmacol Soc. 1995;38:141-3. No abstract available.

PMID:
7480008
25.

[N-methylnorleucine-(28,31)]cholecystokinin-(26-33) (SNF 8702) activity at a cloned rat CCKB receptor.

Knapp RJ, Malatynska E, Peterson P, Zalewska T, Fang S, Hruby VJ, Smith TL, Yamamura HI.

Eur J Pharmacol. 1994 Oct 14;269(2):133-8.

PMID:
7851490
26.

[3H]SNF8702 autoradiography of CCK-B receptors in guinea pig brain and studies with a cloned rat CCK-B receptor.

Knapp RJ, Malatynska E, Hashimoto S, Fang S, Hunt M, Wamsley JK, Peterson P, Zalewska T, Hruby VJ, Yamamura HI.

Ann N Y Acad Sci. 1994 Mar 23;713:380-3. No abstract available.

PMID:
8185194
27.

Characterization of [3H]naltrindole binding to delta opioid receptors in mouse brain and mouse vas deferens: evidence for delta opioid receptor heterogeneity.

Fang L, Knapp RJ, Horvath R, Matsunaga TO, Haaseth RC, Hruby VJ, Porreca F, Yamamura HI.

J Pharmacol Exp Ther. 1994 Feb;268(2):836-46.

PMID:
8113996
28.

Identification of a human delta opioid receptor: cloning and expression.

Knapp RJ, Malatynska E, Fang L, Li X, Babin E, Nguyen M, Santoro G, Varga EV, Hruby VJ, Roeske WR, et al.

Life Sci. 1994;54(25):PL463-9.

PMID:
8201839
29.

Syntheses, opioid binding affinities, and potencies of dynorphin A analogues substituted in positions, 1, 6, 7, 8 and 10.

Kawasaki AM, Knapp RJ, Walton A, Wire WS, Zalewska T, Yamamura HI, Porreca F, Burks TF, Hruby VJ.

Int J Pept Protein Res. 1993 Nov;42(5):411-9.

PMID:
7906258
30.

Design and synthesis of highly potent and selective cyclic dynorphin A analogs. 2. New analogs.

Kawasaki AM, Knapp RJ, Kramer TH, Walton A, Wire WS, Hashimoto S, Yamamura HI, Porreca F, Burks TF, Hruby VJ.

J Med Chem. 1993 Mar 19;36(6):750-7.

PMID:
8096246
31.

Unexpected antinociceptive potency of cyclic [D-Tca1]CTAP: potential for a novel mechanism of action.

Horan PJ, Wild KD, Kazmierski WM, Ferguson R, Hruby VJ, Weber SJ, Davis TP, Fang L, Knapp RJ, Yamamura HI, et al.

Eur J Pharmacol. 1993 Mar 16;233(1):53-62.

PMID:
8386089
32.

Delta opioid receptor radioligands.

Knapp RJ, Yamamura HI.

Biochem Pharmacol. 1992 Nov 3;44(9):1687-95. Review. No abstract available.

PMID:
1333204
33.

Reduced peptide bond cyclic somatostatin based opioid octapeptides. Synthesis, conformational properties and pharmacological characterization.

Kazmierski WM, Ferguson RD, Knapp RJ, Lui GK, Yamamura HI, Hruby VJ.

Int J Pept Protein Res. 1992 May;39(5):401-14.

PMID:
1358847
34.

Synthesis of [D-Ala2,4'-125I-Phe3,Glu4]deltorphin and characterization of its delta opioid receptor binding properties.

Fang L, Knapp RJ, Matsunaga T, Weber SJ, Davis T, Hruby VJ, Yamamura HI.

Life Sci. 1992;51(20):PL189-93.

PMID:
1331636
35.

Characterization of [3H]naltrindole binding to delta opioid receptors in rat brain.

Yamamura MS, Horvath R, Toth G, Otvos F, Malatynska E, Knapp RJ, Porreca F, Hruby VJ, Yamamura HI.

Life Sci. 1992;50(16):PL119-24.

PMID:
1313133
36.

Topographical requirements for delta opioid ligands: presence of a carboxyl group in position 4 is not critical for deltorphin high delta receptor affinity and analgesic activity.

Misicka A, Lipkowski AW, Fang L, Knapp RJ, Davis P, Kramer T, Burks TF, Yamamura HI, Carr DB, Hruby VJ.

Biochem Biophys Res Commun. 1991 Nov 14;180(3):1290-7.

PMID:
1659410
37.

A new type of synthetic peptide library for identifying ligand-binding activity.

Lam KS, Salmon SE, Hersh EM, Hruby VJ, Kazmierski WM, Knapp RJ.

Nature. 1991 Nov 7;354(6348):82-4. Erratum in: Nature 1992 Dec 24-31;360(6406):768. Nature 1992 Jul 30;358(6385):434.

PMID:
1944576
38.

[D-Pen2,4'-125I-Phe4,D-Pen5]enkephalin: a selective high affinity radioligand for delta opioid receptors with exceptional specific activity.

Knapp RJ, Sharma SD, Toth G, Duong MT, Fang L, Bogert CL, Weber SJ, Hunt M, Davis TP, Wamsley JK, et al.

J Pharmacol Exp Ther. 1991 Sep;258(3):1077-83.

PMID:
1653834
39.

Opioid receptor binding properties of analgesic analogues of cholecystokinin octapeptide.

Slaninova J, Knapp RJ, Wu JJ, Fang SN, Kramer T, Burks TF, Hruby VJ, Yamamura HI.

Eur J Pharmacol. 1991 Jul 23;200(1):195-8.

PMID:
1663041
40.

The interaction of a benzodiazepine receptor antagonist (Ro15-1788) with GABA and GABA receptor antagonists at the GABA(A) receptor chloride-ionophore complex.

Malatynska E, Dilsaver SC, Knapp RJ, Giroux ML, Ikeda M, Yamamura HI.

Neurochem Int. 1991;18(3):405-10.

PMID:
20504718
41.

Delta opioid receptor-selective ligands: [D-Pen2,D-Pen5]enkephalin-dermenkephalin chimeric peptides.

Cavagnero S, Misicka A, Knapp RJ, Davis P, Fang L, Burks TF, Yamamura HI, Hruby VJ.

Life Sci. 1991;49(7):495-503.

PMID:
1650414
42.

A new, highly selective CCK-B receptor radioligand ([3H][N-methyl-Nle28,31]CCK26-33): evidence for CCK-B receptor heterogeneity.

Knapp RJ, Vaughn LK, Fang SN, Bogert CL, Yamamura MS, Hruby VJ, Yamamura HI.

J Pharmacol Exp Ther. 1990 Dec;255(3):1278-86.

PMID:
2262906
43.

Design and synthesis of highly potent and selective cyclic dynorphin A analogues.

Kawasaki AM, Knapp RJ, Kramer TH, Wire WS, Vasquez OS, Yamamura HI, Burks TF, Hruby VJ.

J Med Chem. 1990 Jul;33(7):1874-9.

PMID:
1972964
44.

Differentiation between rat brain and mouse vas deferens delta opioid receptors.

Vaughn LK, Wire WS, Davis P, Shimohigashi Y, Toth G, Knapp RJ, Hruby VJ, Burks TF, Yamamura HI.

Eur J Pharmacol. 1990 Feb 20;177(1-2):99-101.

PMID:
2160370
45.

From binding studies to the molecular biology of GABA receptors.

Knapp RJ, Malatynska E, Yamamura HI.

Neurochem Res. 1990 Feb;15(2):105-12. Review. No abstract available.

PMID:
2159117
47.

Structural characteristics of two highly selective opioid peptides.

Knapp RJ, Kazmierski W, Hruby VJ, Yamamura HI.

Bioessays. 1989 Feb-Mar;10(2-3):58-61. Review.

PMID:
2541696
48.

[3H]-[H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2] ([3H]CTOP), a potent and highly selective peptide for mu opioid receptors in rat brain.

Hawkins KN, Knapp RJ, Lui GK, Gulya K, Kazmierski W, Wan YP, Pelton JT, Hruby VJ, Yamamura HI.

J Pharmacol Exp Ther. 1989 Jan;248(1):73-80.

PMID:
2563293
49.

Amoxapine inhibition of GABA-stimulated chloride conductance: investigations of potential sites of activity.

Ikeda M, Knapp RJ, Malatynska E, Yamamura HI.

Life Sci. 1989;45(20):1903-10.

PMID:
2557507
50.

A high affinity, highly selective ligand for the delta opioid receptor: [3H]-[D-Pen2, pCl-Phe4, d-Pen5]enkephalin.

Vaughn LK, Knapp RJ, Toth G, Wan YP, Hruby VJ, Yamamura HI.

Life Sci. 1989;45(11):1001-8.

PMID:
2552241

Supplemental Content

Loading ...
Support Center